Post

SonarMD touts positive data from digital platform at DDW

SonarMD has revealed positive results from two studies, demonstrating that its SonarMD digital platform reduces emergency department visits and inpatient …

MRD endpoint expected to usher new era for MM therapies

Last month, the Oncologic Drugs Advisory Committee (ODAC) for the US Food and Drug Administration (FDA) voted in favour of …

Edgewood Oncology treats first two subjects in breast cancer trial

Edgewood Oncology has treated the first two subjects in the Phase IIa clinical trial of BTX-A51, targeting patients with metastatic …

Vedanta Biosciences doses first subject in Phase III C difficile prevention trial

Vedanta Biosciences has dosed the first subject in Phase III RESTORATiVE303 clinical trial of VE303, a live biotherapeutic product candidate …

AiM Medical Robotics partners with Harvard Hospital for DBS study

AiM Medical Robotics has partnered with Harvard Medical School’s affiliate Brigham and Women's Hospital (BWH) to conduct a study validating …